JCAD Editor in Chief Jim Del Rosso, DO, reports from the 2020 Winter Clinical Dermatology conference to discuss microencapsulation of active ingredients in topical formulations and the host of benefits that accompanies this new technology.
In the third part of this three-part series on oral antibiotic therapy for acne, Dr. Del Rosso discusses the development program for sarecycline, the newest tetracycline-class antibiotic for acne.
In the first of this three-part series on oral antibiotic therapy for acne, Dr. Jim Del Rosso discusses patient counseling around acne treatment plans that include oral antibiotics and reviews the advantages and disadvantages of tetracyclines commonly used to treat acne, including minocycline, doxycycline, and sarecycline.
In the second of this three-part series on oral antibiotic therapy for acne, Dr. Jim Del Rosso discusses antimicrobial considerations, with a focus on differentiating features of the newest tetracycline-class antibiotic for acne, sarecycline.
Dr. Del Rosso compares the difference between polypodium leucotomos (PL) and PL extract (PLE) products available to patients. This is Part 2 of a two-part series.